Fine-tuning the lipogenic/lipolytic balance to optimize the metabolic requirements of cancer cell growth: molecular mechanisms and therapeutic perspectives.
about
A novel approach to the discovery of anti-tumor pharmaceuticals: searching for activators of liponecrosisLipogenesis and lipolysis: the pathways exploited by the cancer cells to acquire fatty acidsLipid biology of breast cancerEfficacy of a non-hypercalcemic vitamin-D2 derived anti-cancer agent (MT19c) and inhibition of fatty acid synthesis in an ovarian cancer xenograft modelDe novo fatty acid biosynthesis contributes significantly to establishment of a bioenergetically favorable environment for vaccinia virus infectionMACC1 decreases the chemosensitivity of gastric cancer cells to oxaliplatin by regulating FASN expression.Lysophosphatidic acid acyltransferase β (LPAATβ) promotes the tumor growth of human osteosarcoma.Monoacylglycerol lipase promotes metastases in nasopharyngeal carcinoma.1-stearoylglycerol is associated with risk of prostate cancer: results from serum metabolomic profiling.Chemical inhibition of acetyl-CoA carboxylase suppresses self-renewal growth of cancer stem cells.Fatty acid synthase phosphorylation: a novel therapeutic target in HER2-overexpressing breast cancer cells.Inactivation of DNA-dependent protein kinase promotes heat-induced apoptosis independently of heat-shock protein induction in human cancer cell lines.Mitochondrial and plasma membrane lactate transporter and lactate dehydrogenase isoform expression in breast cancer cell lines.Myelopoietic efficacy of orlistat in murine hosts bearing T cell lymphoma: implication in macrophage differentiation and activationMonoacylglycerol lipase exerts dual control over endocannabinoid and fatty acid pathways to support prostate cancer.T0901317 inhibits cisplatin-induced apoptosis in ovarian cancer cells [corrected]Metformin: multi-faceted protection against cancer.Hedgehog-mediated regulation of PPARγ controls metabolic patterns in neural precursors and shh-driven medulloblastomaMetabolomic analysis of prostate cancer risk in a prospective cohort: The alpha-tocolpherol, beta-carotene cancer prevention (ATBC) studyMammalian fatty acid synthase activity from crude tissue lysates tracing ¹³C-labeled substrates using gas chromatography-mass spectrometry.Cancer chemopreventive potential of volatile oil from black cumin seeds, Nigella sativa L., in a rat multi-organ carcinogenesis bioassayMolecular signatures of amyotrophic lateral sclerosis disease progression in hind and forelimb muscles of an SOD1(G93A) mouse modelHydroxycarboxylic acid receptors are essential for breast cancer cells to control their lipid/fatty acid metabolismInhibition of glucose-6-phosphate dehydrogenase sensitizes cisplatin-resistant cells to death.Biochemistry and pathophysiology of intravascular and intracellular lipolysis.Chronic psychological stress and its impact on the development of aggressive breast cancer.The metastasis inducer CCN1 (CYR61) activates the fatty acid synthase (FASN)-driven lipogenic phenotype in breast cancer cells.PPARs and Mitochondrial Metabolism: From NAFLD to HCC.Mammary adipocytes stimulate breast cancer invasion through metabolic remodeling of tumor cells.Suppression of endogenous lipogenesis induces reversion of the malignant phenotype and normalized differentiation in breast cancer.Emerging roles of lipid metabolism in cancer metastasis.Potential of olive oil phenols as chemopreventive and therapeutic agents against cancer: a review of in vitro studies.The mitochondrial H(+)-ATP synthase and the lipogenic switch: new core components of metabolic reprogramming in induced pluripotent stem (iPS) cells.mRNA expression of nuclear factor of activated T-cells, cytoplasmic 2 (NFATc2) and peroxisome proliferator-activated receptor gamma (PPARG) transcription factors in colorectal carcinoma.Antitumour effects of tetrazanbigen against human hepatocellular carcinoma QGY-7701 through inducing lipid accumulation in vitro and in vivo.Energy sources identify metabolic phenotypes in pancreatic cancer.PPARs: Interference with Warburg' Effect and Clinical Anticancer Trials.High lysophosphatidylcholine acyltransferase 1 expression independently predicts high risk for biochemical recurrence in prostate cancers.Targeting metabolism and AMP-activated kinase with metformin to sensitize non-small cell lung cancer (NSCLC) to cytotoxic therapy: translational biology and rationale for current clinical trials.Docosahexaenoic Acid Modulates a HER2-Associated Lipogenic Phenotype, Induces Apoptosis, and Increases Trastuzumab Action in HER2-Overexpressing Breast Carcinoma Cells.
P2860
Q26774351-80F58FFC-8505-4262-9915-B2D4C34C45DFQ26996516-DE3349A8-80A5-4886-BA73-99C1E66313B8Q27013858-C10CE62F-5005-4621-A46A-5A1933A5443FQ28482093-7195682B-83AC-47B3-B761-3392628B81F5Q28541249-79402226-0935-4A73-83A7-D9B9503AF4AEQ33673940-D3A7C5F4-7092-4311-A750-5DE6EBD308B9Q33769959-E60A9B5E-F1B4-49D7-90E5-DE4ABE5C4F12Q34028928-D47E9070-BCCE-41C2-815F-385429907826Q34218543-628C5EE7-917A-465B-B56E-FBEB4A0CBD3CQ34483548-076E2F81-8FDD-4294-B71A-E9694E661ECEQ34613543-BB60959B-71B4-48B3-BAE9-B0D619208BF8Q34625724-90615E0A-7CF3-40E0-98DE-627B83B1A487Q34746073-414B53F0-7833-4FE5-ACD0-EDF2B148831DQ35070248-4873BA06-85F7-489F-92C2-7C8ACBB0E777Q35146525-F0A8EB94-E6E1-4978-B462-20407E886F6DQ35464846-7D5917A6-C09F-492F-8F88-E19606B5340BQ35764409-0155D67F-0A9A-4308-9219-815FB8A44BF3Q35837389-B877C561-16B0-40CD-B052-9C7263D89137Q35957484-C2F131E5-06FA-49E8-A085-B9177AC04201Q36152148-A0751DDF-FA47-4114-B962-DA25D4CB517BQ36216121-58073D6C-9F74-4BE0-8170-D65C3892BDB2Q36218785-DCF32156-191C-46F0-B192-81CB1EC66F66Q36260625-37B16B45-C568-404E-B674-B86AA63681ABQ36557513-FB3E909A-F8D3-47F9-B533-889D95A49D43Q36708030-143E25AD-F567-40DA-A929-5B80A1DDC477Q37092151-3D3F8E42-82EA-4EE7-AF86-12001FA9E3F8Q37298189-D25F4B7F-1BB7-45BD-BAA6-CA2D2D618335Q37575571-9FA4CBE9-E2AC-4150-8187-CFE9C093A6AAQ37646868-F1F8FAEB-14F2-4424-A8B4-9A743C26299CQ37687587-D724FCFF-D96C-4971-865B-B2B456F2C44FQ37747513-CD445B94-64FF-4188-8772-71D629C2690EQ38063484-7BA82C7A-29E5-4877-8D6E-5B6CFC987A77Q38071479-037C5531-51BD-463E-96BE-B564F45A12C2Q38703520-B8EB32D5-1328-459E-8149-CF86D9695DDAQ38846089-23C888D4-CEF9-4539-BC60-34620ECB87F7Q38959840-F4B36C30-157B-479B-8AC7-A5A5C534CAACQ39609137-331566C8-CD38-4DE4-85EE-A0416720760AQ41134388-0627066F-2D20-40AA-A416-FDB824D41DF9Q41339882-2FA989F5-9010-4E36-BE09-E48A22B42B3EQ41846641-09ED8746-3CF6-403C-BC15-924F36BDB24D
P2860
Fine-tuning the lipogenic/lipolytic balance to optimize the metabolic requirements of cancer cell growth: molecular mechanisms and therapeutic perspectives.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Fine-tuning the lipogenic/lipo ...... and therapeutic perspectives.
@en
Fine-tuning the lipogenic/lipo ...... and therapeutic perspectives.
@nl
type
label
Fine-tuning the lipogenic/lipo ...... and therapeutic perspectives.
@en
Fine-tuning the lipogenic/lipo ...... and therapeutic perspectives.
@nl
prefLabel
Fine-tuning the lipogenic/lipo ...... and therapeutic perspectives.
@en
Fine-tuning the lipogenic/lipo ...... and therapeutic perspectives.
@nl
P1476
Fine-tuning the lipogenic/lipo ...... s and therapeutic perspectives
@en
P2093
Javier A Menendez
P304
P356
10.1016/J.BBALIP.2009.09.005
P407
P577
2009-09-24T00:00:00Z